PROTEINASE K MARKET ANALYSIS

Proteinase K Market, By Form (Lyophilized Powder Form, Liquid Form), By Application (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End User (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2023
Code : CMI3548
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Companies covered:

Major players operating in the Global Proteinase K Market include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd., New England Biolabs, Worthington Biochemical Corporation, Norgen Biotek Corp., BIORON GmbH, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.), Promega Corporation.

Key players in the market are adopting various strategies such as partnerships, mergers and acquisitions, joint ventures, and strategic collaborations to expand their market presence. For instance, on February 23, 2022, Merck KGaA, a Germany-based pharmaceutical company acquired Exelead, a U.S.-based pharmaceutical company, and announced plans to invest approximately US$ 542 million for scaling up its technology. The initiative is expected to broaden the company’s portfolio of offerings and can positively affect its growth.